Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158333372> ?p ?o ?g. }
- W2158333372 endingPage "9788" @default.
- W2158333372 startingPage "9779" @default.
- W2158333372 abstract "Candidate human immunodeficiency virus type 1 (HIV-1) vaccines designed to elicit T-cell immunity in HIV-1-uninfected persons are under investigation in phase I to III clinical trials. Little is known about how these vaccines impact the immunologic response postinfection in persons who break through despite vaccination. Here, we describe the first comprehensive characterization of HIV-specific T-cell immunity in vaccine study participants following breakthrough HIV-1 infection in comparison to 16 nonvaccinated subjects with primary HIV-1 infection. Whereas none of the 16 breakthrough infections possessed vaccine-induced HIV-1-specific T-cell responses preinfection, 85% of vaccinees and 86% of nonvaccinees with primary HIV-1 infection developed HIV-specific T-cell responses postinfection. Breakthrough subjects' T cells recognized 43 unique HIV-1 T-cell epitopes, of which 8 are newly described, and 25% were present in the vaccine. The frequencies of gamma interferon (IFN-gamma)-secreting cells recognizing epitopes within gene products that were and were not encoded by the vaccine were not different (P = 0.64), which suggests that responses were not anamnestic. Epitopes within Nef and Gag proteins were the most commonly recognized in both vaccinated and nonvaccinated infected subjects. One individual controlled viral replication without antiretroviral therapy and, notably, mounted a novel HIV-specific HLA-C14-restricted Gag LYNTVATL-specific T-cell response. Longitudinally, HIV-specific T cells in this individual were able to secrete IFN-gamma and tumor necrosis factor alpha, as well as proliferate and degranulate in response to their cognate antigenic peptides up to 5 years postinfection. In conclusion, a vaccinee's ability to mount an HIV-specific T-cell response postinfection is not compromised by previous immunization, since the CD8+ T-cell responses postinfection are similar to those seen in vaccine-naïve individuals. Finding an individual who is controlling infection highlights the importance of comprehensive studies of breakthrough infections in vaccine trials to determine whether host genetics/immune responses and/or viral characteristics are responsible for controlling viral replication." @default.
- W2158333372 created "2016-06-24" @default.
- W2158333372 creator A5001827327 @default.
- W2158333372 creator A5011120950 @default.
- W2158333372 creator A5018875016 @default.
- W2158333372 creator A5021587460 @default.
- W2158333372 creator A5038372794 @default.
- W2158333372 creator A5040421992 @default.
- W2158333372 creator A5050750455 @default.
- W2158333372 creator A5061870609 @default.
- W2158333372 creator A5073284312 @default.
- W2158333372 creator A5073940048 @default.
- W2158333372 creator A5084520588 @default.
- W2158333372 creator A5090773831 @default.
- W2158333372 date "2006-10-01" @default.
- W2158333372 modified "2023-10-16" @default.
- W2158333372 title "Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses in HIV Vaccine Trial Participants Who Subsequently Acquire HIV-1 Infection" @default.
- W2158333372 cites W1479760379 @default.
- W2158333372 cites W1969498684 @default.
- W2158333372 cites W1973239147 @default.
- W2158333372 cites W2001815433 @default.
- W2158333372 cites W2008972159 @default.
- W2158333372 cites W2039905832 @default.
- W2158333372 cites W2048829583 @default.
- W2158333372 cites W2062263111 @default.
- W2158333372 cites W2064044870 @default.
- W2158333372 cites W2084675654 @default.
- W2158333372 cites W2087320996 @default.
- W2158333372 cites W2099067260 @default.
- W2158333372 cites W2112601022 @default.
- W2158333372 cites W2112664283 @default.
- W2158333372 cites W2113983720 @default.
- W2158333372 cites W2125400731 @default.
- W2158333372 cites W2127688496 @default.
- W2158333372 cites W2135883251 @default.
- W2158333372 cites W2138723840 @default.
- W2158333372 cites W2142577196 @default.
- W2158333372 cites W2147333339 @default.
- W2158333372 cites W2149915096 @default.
- W2158333372 cites W2151651155 @default.
- W2158333372 cites W2154310954 @default.
- W2158333372 cites W2155167450 @default.
- W2158333372 cites W2155612027 @default.
- W2158333372 cites W2156392662 @default.
- W2158333372 cites W2162322548 @default.
- W2158333372 cites W2318162832 @default.
- W2158333372 cites W4247902509 @default.
- W2158333372 doi "https://doi.org/10.1128/jvi.00794-06" @default.
- W2158333372 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1617262" @default.
- W2158333372 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16973582" @default.
- W2158333372 hasPublicationYear "2006" @default.
- W2158333372 type Work @default.
- W2158333372 sameAs 2158333372 @default.
- W2158333372 citedByCount "19" @default.
- W2158333372 countsByYear W21583333722013 @default.
- W2158333372 countsByYear W21583333722014 @default.
- W2158333372 countsByYear W21583333722015 @default.
- W2158333372 countsByYear W21583333722016 @default.
- W2158333372 countsByYear W21583333722017 @default.
- W2158333372 countsByYear W21583333722019 @default.
- W2158333372 countsByYear W21583333722022 @default.
- W2158333372 crossrefType "journal-article" @default.
- W2158333372 hasAuthorship W2158333372A5001827327 @default.
- W2158333372 hasAuthorship W2158333372A5011120950 @default.
- W2158333372 hasAuthorship W2158333372A5018875016 @default.
- W2158333372 hasAuthorship W2158333372A5021587460 @default.
- W2158333372 hasAuthorship W2158333372A5038372794 @default.
- W2158333372 hasAuthorship W2158333372A5040421992 @default.
- W2158333372 hasAuthorship W2158333372A5050750455 @default.
- W2158333372 hasAuthorship W2158333372A5061870609 @default.
- W2158333372 hasAuthorship W2158333372A5073284312 @default.
- W2158333372 hasAuthorship W2158333372A5073940048 @default.
- W2158333372 hasAuthorship W2158333372A5084520588 @default.
- W2158333372 hasAuthorship W2158333372A5090773831 @default.
- W2158333372 hasBestOaLocation W21583333721 @default.
- W2158333372 hasConcept C147483822 @default.
- W2158333372 hasConcept C159047783 @default.
- W2158333372 hasConcept C195616568 @default.
- W2158333372 hasConcept C203014093 @default.
- W2158333372 hasConcept C22070199 @default.
- W2158333372 hasConcept C2522874641 @default.
- W2158333372 hasConcept C2776090121 @default.
- W2158333372 hasConcept C2778190748 @default.
- W2158333372 hasConcept C2779341262 @default.
- W2158333372 hasConcept C2779690655 @default.
- W2158333372 hasConcept C2780195530 @default.
- W2158333372 hasConcept C2780727368 @default.
- W2158333372 hasConcept C2910359755 @default.
- W2158333372 hasConcept C3017875465 @default.
- W2158333372 hasConcept C86803240 @default.
- W2158333372 hasConcept C8891405 @default.
- W2158333372 hasConceptScore W2158333372C147483822 @default.
- W2158333372 hasConceptScore W2158333372C159047783 @default.
- W2158333372 hasConceptScore W2158333372C195616568 @default.
- W2158333372 hasConceptScore W2158333372C203014093 @default.
- W2158333372 hasConceptScore W2158333372C22070199 @default.
- W2158333372 hasConceptScore W2158333372C2522874641 @default.
- W2158333372 hasConceptScore W2158333372C2776090121 @default.